What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Antibiotics
His primary areas of study are Internal medicine, Antibiotics, Antibacterial agent, Microbiology and Acinetobacter baumannii.
His biological study spans a wide range of topics, including Bacteremia and Surgery.
His Antibiotics research includes elements of Pharmacotherapy, Drug resistance and Intensive care medicine.
The Antibacterial agent study which covers Pharmacology that intersects with Aminoglycoside.
Matthew E. Falagas interconnects Klebsiella pneumoniae and Gram-negative bacteria in the investigation of issues within Microbiology.
His Acinetobacter baumannii research is multidisciplinary, incorporating perspectives in Case-control study and Colistin.
His most cited work include:
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance (4863 citations)
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance (4863 citations)
- Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses (1479 citations)
What are the main themes of his work throughout his whole career to date?
Matthew E. Falagas spends much of his time researching Internal medicine, Surgery, Intensive care medicine, Antibiotics and Antibacterial agent.
His biological study spans a wide range of topics, including Bacteremia, Ciprofloxacin and Incidence.
The study incorporates disciplines such as Pharmacotherapy and Epidemiology in addition to Intensive care medicine.
His Antibiotics study combines topics from a wide range of disciplines, such as Antimicrobial and Drug resistance.
The Meta-analysis study combines topics in areas such as Relative risk and Confidence interval.
His research integrates issues of Nephrotoxicity, Acinetobacter baumannii, Polymyxin and Polymyxin B in his study of Colistin.
He most often published in these fields:
- Internal medicine (59.35%)
- Surgery (47.56%)
- Intensive care medicine (36.28%)
What were the highlights of his more recent work (between 2012-2021)?
- Internal medicine (59.35%)
- Antibiotics (33.94%)
- Intensive care medicine (36.28%)
In recent papers he was focusing on the following fields of study:
Matthew E. Falagas focuses on Internal medicine, Antibiotics, Intensive care medicine, Meta-analysis and Microbiology.
The various areas that Matthew E. Falagas examines in his Internal medicine study include Bacteremia and Surgery.
In general Antibiotics study, his work on Multiple drug resistance often relates to the realm of Bronchiectasis, thereby connecting several areas of interest.
His work deals with themes such as Immunology and Acinetobacter, which intersect with Multiple drug resistance.
His work investigates the relationship between Intensive care medicine and topics such as Drug resistance that intersect with problems in Methicillin-resistant Staphylococcus aureus and Staphylococcus aureus.
As a member of one scientific family, Matthew E. Falagas mostly works in the field of Microbiology, focusing on Enterobacteriaceae and, on occasion, Pharmacotherapy and Klebsiella pneumoniae.
Between 2012 and 2021, his most popular works were:
- Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. (296 citations)
- Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence (234 citations)
- Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of Carbapenems and Piperacillin/Tazobactam: A Systematic Review and Meta-analysis (207 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Antibiotics
His scientific interests lie mostly in Internal medicine, Meta-analysis, Intensive care medicine, Randomized controlled trial and Surgery.
His Internal medicine study combines topics in areas such as Bacteremia and Pseudomonas aeruginosa.
His research in Intensive care medicine intersects with topics in Multiple drug resistance, Antibiotics, University hospital, Pneumonia and Acinetobacter baumannii.
Matthew E. Falagas combines subjects such as Plazomicin and Adverse effect with his study of Antibiotics.
His work carried out in the field of Randomized controlled trial brings together such families of science as Pharmacodynamics and Pediatrics.
Matthew E. Falagas has included themes like Colistin and Microbiology in his Vancomycin study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
